Mont-Saint-Guibert, Belgium – Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the company plans to participate at the following virtual investor conferences in March 2021:
H.C. Wainwright Global Life Sciences Conference
Date: Tuesday, March 9 – Wednesday, March 10, 2021
Time: 7:00 a.m. ET / 1:00 p.m. CET
Webcast: A webcast of the presentation will be available in the Events section of the Celyad Oncology website for approximately 90 days from the start of the event.
BioCapital Europe
Date: Thursday, March 11, 2021
Time: 9:50 a.m. ET / 3:50 p.m. CET
